Saturday, May 25, 2024
HomeIndustry NewsUSDA Center for Veterinary Biologics Allows Groundbreaking Platform Technology Portfolio of Vaccines...

USDA Center for Veterinary Biologics Allows Groundbreaking Platform Technology Portfolio of Vaccines to Pork Industry

(Brookings, SD) — The USDA Center for Veterinary Biologics (CVB) has allowed animal health company,  Medgene, license to produce and market a USDA – approved Platform Vaccine to the pork industry. The  license applies to use of their Platform technology to produce vaccines addressing disease targets such  as Rotavirus, Porcine Circovirus, Influenza A, and Sapovirus. 

Medgene’s vaccine approach leverages a USDA-approved “platform technology” that is safe and easily  adapted to multiple animal disease targets. The result is the development of vaccines and an  understanding of how diseases move across species and geographies in a fraction of the time of  traditional vaccine approaches.  

Dr. Clayton Johnson, Director of Veterinary Services for Carthage Veterinary Service, LTD, stated,  “Medgene’s approach to Platform Vaccines allows us to keep our standards of animal health at the  highest level possible.” 

Medgene announced their licensure on June 8 at the World Pork Expo, held on the Iowa State Fair  fairgrounds, located in Des Moines, Iowa. 

Medgene CEO, Mark Luecke, stated, “The pork industry’s importance to our nation’s food supply can’t  be overstated. We’ve been working on getting the power of Platform technology into the hands of pork  industry veterinarians for many years. Our license means we can bring the safety, speed, and value of  this technology to work for the good of the industry.” 

Medgene’s Rotavirus, Porcine Circovirus, Influenza A, and Sapovirus vaccines are available to licensed  veterinarians.

RELATED ARTICLES
- Advertisment -

Latest Stories